Your browser doesn't support javascript.
loading
Phase 1b Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed, Transplant-ineligible Multiple Myeloma Patients.
Ocio, Enrique M; Bringhen, Sara; Martinez-Lopez, Joaquin; San-Miguel, Jesus; Oliva, Stefania; Rodriguez-Otero, Paula; Le Roux, Nadia; Dong, Yvonne; Doroumian, Severine; Macé, Sandrine; Mateos, Maria-Victoria.
Afiliação
  • Ocio EM; Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain.
  • Bringhen S; SSD Clinical Trials in Onco-Ematologia e Myeloma Multiplo, AOU Città della Salute e della Scienza di Torino, Italy.
  • Martinez-Lopez J; Hematology, Hospital Universitario 12 de Octubre, CNIO, Universidad Complutense de Madrid, Spain.
  • San-Miguel J; University Clinic of Navarra, CCUN, Center for Applied Medical Research (CIMA), IDISNA, CIBERONC, Pamplona, Spain.
  • Oliva S; SSD Clinical Trials in Onco-Ematologia e Myeloma Multiplo, AOU Città della Salute e della Scienza di Torino, Italy.
  • Rodriguez-Otero P; University Clinic of Navarra, CCUN, Center for Applied Medical Research (CIMA), IDISNA, CIBERONC, Pamplona, Spain.
  • Le Roux N; Altran, Neuilly Sur Seine, France, on behalf of Sanofi.
  • Dong Y; Sanofi, Bejing, China.
  • Doroumian S; Sanofi, Montpellier, France.
  • Macé S; Sanofi, Translational Medicine, Chilly-Mazarin, France.
  • Mateos MV; University Hospital of Salamanca and Cancer Research Center (IBMCC-CSIC-USAL), Salamanca, Spain.
Hemasphere ; 7(2): e829, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36751513
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article